Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2017 Nov 1;3(11):1495-1502.
doi: 10.1001/jamaoncol.2017.1256.

Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy

Nariya Cho  1 , Wonshik Han  2 , Boo-Kyung Han  3 , Min Sun Bae  1 , Eun Sook Ko  3 , Seok Jin Nam  4 , Eun Young Chae  5 , Jong Won Lee  6 , Sung Hun Kim  7 , Bong Joo Kang  7 , Byung Joo Song  8 , Eun-Kyung Kim  9 , Hee Jung Moon  9 , Seung Il Kim  10 , Sun Mi Kim  11 , Eunyoung Kang  12 , Yunhee Choi  13 , Hak Hee Kim  5 , Woo Kyung Moon  1
Affiliations
Observational Study

Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy

Nariya Cho et al. JAMA Oncol. .

Abstract

Importance: Younger women (aged ≤50 years) who underwent breast conservation therapy may benefit from breast magnetic resonance imaging (MRI) screening as an adjunct to mammography.

Objective: To prospectively determine the cancer yield and tumor characteristics of combined mammography with MRI or ultrasonography screening in women who underwent breast conservation therapy for breast cancers and who were 50 years or younger at initial diagnosis.

Design, setting, and participants: This multicenter, prospective, nonrandomized study was conducted from December 1, 2010, to January 31, 2016, at 6 academic institutions. Seven hundred fifty-four women who were 50 years or younger at initial diagnosis and who had undergone breast conservation therapy for breast cancer were recruited to participate in the study. Reference standard was defined as a combination of pathology and 12-month follow-up.

Interventions: Participants underwent 3 annual MRI screenings of the conserved and contralateral breasts in addition to mammography and ultrasonography, with independent readings.

Main outcomes and measures: Cancer detection rate, sensitivity, specificity, interval cancer rate, and characteristics of detected cancers.

Results: A total of 754 women underwent 2065 mammograms, ultrasonography, and MRI screenings. Seventeen cancers were diagnosed, and most of the detected cancers (13 of 17 [76%]) were stage 0 or stage 1. Overall cancer detection rate (8.2 vs 4.4 per 1000; P = .003) or sensitivity (100% vs 53%; P = .01) of mammography with MRI was higher than that of mammography alone. After the addition of ultrasonography, the cancer detection rate was higher than that by mammography alone (6.8 vs 4.4 per 1000; P = .03). The specificity of mammography with MRI or ultrasonography was lower than that by mammography alone (87% or 88% vs 96%; P < .001). No interval cancer was found.

Conclusions and relevance: After breast conservation therapy in women 50 years or younger, the addition of MRI to annual mammography screening improves detection of early-stage but biologically aggressive breast cancers at acceptable specificity. Results from this study can inform patient decision making on screening methods after breast conservation therapy.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure.
Figure.. Flowchart of Study Protocol
MRI indicates magnetic resonance imaging.
See this image and copyright information in PMC

References

    1. Darby S, McGale P, Correa C, et al. ; Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) . Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378(9804):1707-1716. - PMC - PubMed
    1. Wapnir IL, Anderson SJ, Mamounas EP, et al. . Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol. 2006;24(13):2028-2037. - PubMed
    1. Cuzick J, Sestak I, Baum M, et al. ; ATAC/LATTE investigators . Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol. 2010;11(12):1135-1141. - PubMed
    1. Houssami N, Ciatto S, Martinelli F, Bonardi R, Duffy SW. Early detection of second breast cancers improves prognosis in breast cancer survivors. Ann Oncol. 2009;20(9):1505-1510. - PubMed
    1. Khatcheressian JL, Hurley P, Bantug E, et al. ; American Society of Clinical Oncology . Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(7):961-965. - PubMed

MeSH terms